Acton, MA, United States of America

Phillips W Robbins

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: New England Biolabs, Inc., Millennium Pharmaceuticals Limited, Omnigene, Inc.. Active years: 1993-2006.

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Beverly, MA (US) (1993 - 1998)
  • Acton, MA (US) (1999 - 2006)

Company Filing History:


Years Active: 1993-2006

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Phillips W. Robbins

Introduction

Phillips W. Robbins is an accomplished inventor based in Newburyport, MA (US). He is currently associated with Glycosyn LLC, a company that focuses on innovative solutions in the field of glycoscience. Despite having no patents to his name, Robbins has made significant contributions to his field through his work and collaborations.

Latest Patents

Phillips W. Robbins has not registered any patents as of now. However, his expertise and knowledge in glycoscience continue to influence his work at Glycosyn LLC.

Career Highlights

Robbins has built a career centered around research and development in glycoscience. His role at Glycosyn LLC has allowed him to explore various innovative projects that aim to advance the understanding and application of glycoscience in different industries.

Collaborations

Robbins works closely with his coworker, John M. McCoy, at Glycosyn LLC. Their collaboration is focused on developing new methodologies and solutions that can enhance the effectiveness of glycoscience applications.

Conclusion

Phillips W. Robbins is a dedicated inventor whose work at Glycosyn LLC showcases his commitment to innovation in glycoscience. His contributions, although not yet reflected in patents, are valuable to the ongoing advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…